Ultrasound-enhanced intrascleral delivery of protein

International Journal of Pharmaceutics

Volumn 401, Issue 1-2, 2010, Pages 16-24

  Cheung, Alex Chi Yeung ^a   Yu, Yu ^a   Tay, David ^b   Wong, Hoi Sang ^a   Ellis Behnke, Rutledge ^b   Chau, Ying ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cavitation; Non invasive; Ocular delivery; Posterior segment; Sonophoresis

Indexed keywords

BOVINE SERUM ALBUMIN; FLUORESCEIN ISOTHIOCYANATE; PROTEIN;

ANIMAL TISSUE; ARTICLE; CONJUGATION; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; HISTOLOGY; IMMERSION; MEASUREMENT; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINA; SCLERA; THERMODYNAMICS; ULTRASOUND;

EID: 78049261849     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.09.001     Document Type: Article

References (47)

1. Ambati J., Canakis C.S., Miller J.W., Gragoudas E.S., Edwards A., Weissgold D.J., Kim I., Delori F.C., Adamis A.P. Diffusion of high molecular weight compounds through sclera. Invest. Ophthalmol. Vis. Sci. 2000, 41:1181-1185.
2. Anderson O.A., Jackson T.L., Singh J.K., Hussain A.A., Marshall J. Human transscleral albumin permeability and the effect of topographical location and donor age. Invest. Ophthalmol. Vis. Sci. 2008, 49:4041-4045.
3. Atchley A.A., Crum L.A. Acoustic cavitation and bubble dynamics. Ultrasound: Its Chemical, Physical, and Biological Effects 1988, VCH Publishers, New York. K.S. Suslick (Ed.).
4. Benwell A.D., Bly S.H.P. Sources and applications of ultrasound. Ultrasound: Medical Application, Biological Effects and Hazard Potentials 1987, 29-47. Plenum Press, New York. M. Repacholi, M. Grandolfo, A. Rindi (Eds.).
5. Blinc A., Francis C.W., Trudnowski J.L., Carstensen E.L. Characterization of ultrasound-potentiated fibrinolysis in vitro. Blood 1993, 81:2636-2643.
6. Braaten J.V., Goss R.A., Francis C.W. Ultrasound reversibly disaggregates fibrin fibers. J. Thromb. Haemost. 1997, 78:1063-1068.
7. Clarke L., Edwards A., Graham E. Acoustic streaming: an in vitro study. Ultrasound Med. Biol. 2004, 30:559-562.
8. Collis J., Manasseh R., Liovic P., Tho P., Ooi A., Petkovic-Duran K., Zhu Y. Cavitation microstreaming and stress fields created by microbubbles. Ultrasonics 2010, 50:273-279.
9. Coussios C.C., Roy R.A. Applications of acoustics and cavitation to noninvasive therapy and drug delivery. Annu. Rev. Fluid Mech. 2008, 40:395-420.
10. Cruysberg L.P.J., Nuijts R.M.M.A., Geroski D.H., Gilbert J.A., Hendrikse F., Edelhauser H.F. The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds. Invest. Ophthalmol. Vis. Sci. 2005, 46:3790-3794.
11. Edward J.T. Molecular volumes and the Stokes-Einstein equation. J. Chem. Educ. 1970, 47:261-270.
12. Farny C.H., Holt R.G., Roy R.A. Temporal and spatial detection of Hifu-induced inertial and hot-vapor cavitation with a diagnostic ultrasound system. Ultrasound Med. Biol. 2009, 35:603-615.
13. Edwards A., Prausnitz M.R. Fiber matrix model of sclera and corneal stroma for drug delivery to the eye. AIChE J. 1998, 44:214-225.
14. Geroski D.H., Edelhauser H.F. Transscleral drug delivery for posterior segment disease. Adv. Drug Deliv. Rev. 2001, 52:37-48.
15. Hamalainen K.M., Kananen K., Auriola S., Kontturi K., Urtti A. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest. Ophthalmol. Vis. Sci. 1997, 38:627-634.
16. Hay E.D. Cell Biology of Extracellular Matrix 1981, Plenum Press, New York.
17. Janoria K.G., Gunda S., Boddu S.H., Mitra A.K. Novel approaches to retinal drug delivery. Expert Opin. Drug Deliv. 2007, 4:371-388.
18. Holland C.K., Apfel R.E. An improved theory for the prediction of microcavitation thresholds. IEEE Trans. Ultrason. Ferroelectr. Freq. Control. 1989, 36:204-208.
19. Jiang J., Moore J.S., Edelhauser H.F., Prausnitz M.R. Intrascleral drug delivery to the eye using hollow microneedles. Pharm. Res. 2009, 26:395-403.
20. Kim S.H., Lutz R.J., Wang N.S., Robinson M.R. Transport barriers in transscleral drug delivery for retinal diseases. Ophthal. Res. 2007, 39:244-254.
21. Kourlas H., Abrams P. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review. Clin. Ther. 2007, 29:1850-1861.
22. Kremer F.B., Walton P., Gensheimer G. Determination of corneal thickness using ultrasonic pachometry. Ann. Ophthalmol. 1985, 17:506-507.
23. Leighton T.G. The Acoustic Bubble 1994, Academic Press, London.
24. Leighton T.G. Acoustic bubble detection. I. The detection of stable gas bodies. Environ. Eng. 1994, 7:9-16.
25. Leighton T.G. Acoustic bubble detection. II. The detection of transient cavitation. Environ. Eng. 1995, 8:16-25.
26. Lavon I., Kost J. Ultrasound and transdermal drug delivery. Drug Discov. Today 2004, 9:670-676.
27. Lewin P.A., Bjorno L. Thresholds for rectified diffusion and acoustic microstreaming by bubbles in biological tissue. Appl. Sci. Res. 1982, 38:25-35.
28. Maurice D.M., Polgar J. Diffusion across sclera. Exp. Eye Res. 1977, 25:577-582.
29. McDermott M.L., Puklin J.E., Abrams G.W., Eliott D. Phacoemulsification for cataract following pars plana vitrectomy. Ophthal. Surg. Lasers 1997, 28:558-564.
30. Merino G., Kalia Y.N., Guy R.H. Ultrasound-enhanced transdermal transport. J. Pharm. Sci. 2003, 92:1125-1137.
31. Mitragotri S., Blankschtein D., Langer R. Ultrasound-mediated transdermal protein delivery. Science 1995, 269:850-853.
32. Myles M.E., Neumann D.M., Hill J.M. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Adv. Drug Deliv. Rev. 2005, 57:2063-2079.
33. Nomoto H., Shiraga F., Kuno N., Kimura E., Fujii S., Shinomiya K., Nugent A.K., Hirooka K., Baba T. Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits. Invest. Ophthalmol. Vis. Sci. 2009, 50:4807-4813.
34. Parkinson T.M., Ferguson E., Febbraro S., Bakhtyari A., King M., Mundasad M. Tolerance of ocular iontophoresis in healthy volunteers. J. Ocul. Pharmacol. Ther. 2003, 19:145-151.
35. Pavlin C.J., Harasiewicz K., Sherar M.D., Foster F.S. Clinical use of ultrasound biomicroscopy. Ophthalmology 1991, 98:287-295.
36. Perren F., Loulidi J., Poglia D., Landis T., Sztajzel R. Microbubble potentiated transcranial duplex ultrasound enhances IV thrombolysis in acute stroke. J. Thromb. Thrombol. 2008, 25:219-223.
37. Prince J.H., McConnell D.G. The Rabbit in the Eye Research 1964, Charles C Thomas, Springfield, IL.
38. Rockville M. Information for Manufacturers Seeking Marking Clearance of Diagnostic Ultrasound Systems and Transducers 1997, Center for Devices and Radiological Health. F.D.A. Administration (Ed.).
39. Saltzman W.M. Drug Delivery-Engineering Principles for Drug Therapy 2001, Oxford University Press, Inc., New York.
40. Sieving P.A., Caruso R.C., Tao W., Coleman H.R., Thompson D.J., Fullmer K.R., Bush R.A. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(10):3896-3901.
41. Van Krevelen D.W. Properties of Polymers, Their Estimation and Correction with Chemical Structure 1976, Elsevier, New York.
42. Watson P.G., Young R.D. Scleral structure, organisation and disease. A review. Exp. Eye Res. 2004, 78:609-623.
43. Yokoi H., Kinoshita T., Zhang S. Dynamic reassembly of peptide RADA16 nanofiber scaffold. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8414-8419.
44. Zarbin M., Szirth B. Current treatment of age-related macular degeneration. Optom. Vis. Sci. 2007, 84:559-572.
45. Zderic V., Clark J.I., Martin R.W., Vaezy S. Ultrasound-enhanced transcorneal drug delivery. Cornea 2004, 23:804-811.
46. Zderic V., Clark J.I., Vaezy S. Drug delivery into the eye with the use of ultrasound. J. Ultrasound Med. 2004, 23:1349-1359.
47. Zderic V., Vaezy S., Martin R.W., Clark J.I. Ocular drug delivery using 20-kHz ultrasound. Ultrasound Med. Biol. 2002, 28:823-829.